Home > Boards > US Listed > Biotechs > Global Blood Therapeutics (GBT)

What turd! Company is going under

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Goldmind Member Profile
 
Followed By 38
Posts 4,331
Boards Moderated 0
Alias Born 10/19/14
160x600 placeholder
Wells Fargo Thinks Global Blood Therapeutics’ Stock is Going to Recover TipRanks - 1/14/2022 4:07:49 AM
Global Blood Therapeutics price target lowered at Cantor on COVID headwinds for Oxbryta Seeking Alpha - 1/13/2022 4:01:51 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/10/2022 8:03:00 AM
Oxbryta® (voxelotor) Tablets for Oral Suspension, A New Dispersible Tablet Dosage Form, Now Available for Patients with Sickle Cell Disease in the United States GlobeNewswire Inc. - 1/10/2022 8:00:00 AM
GBT Announces New Employment Inducement Grants GlobeNewswire Inc. - 1/6/2022 8:00:00 AM
GBT to Present at the 40th Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. - 1/4/2022 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/17/2021 5:10:14 PM
Global Blood Gets FDA Approval of Supplemental New Drug Application for Oxbryta Dow Jones News - 12/17/2021 2:57:00 PM
Global Blood Therapeutics granted FDA label expansion for sickle cell disease therapy Seeking Alpha - 12/17/2021 2:08:43 PM
U.S. FDA Approves Supplemental New Drug Application for Expanded Indication of Oxbryta® (voxelotor) for Children as Young as 4 Years of Age with Sickle Cell Disease GlobeNewswire Inc. - 12/17/2021 2:05:00 PM
Global Blood Therapeutics wins EU backing for sickle cell disease therapy Seeking Alpha - 12/17/2021 11:12:49 AM
GBT’s Oxbryta® (voxelotor) Receives Positive CHMP Opinion for the Treatment of Hemolytic Anemia in Patients with Sickle Cell Disease Aged 12 Years and Older GlobeNewswire Inc. - 12/17/2021 10:33:26 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/15/2021 4:23:43 PM
Global Blood Therapeutics up 8% following upsized $300M private offering Seeking Alpha - 12/15/2021 2:35:02 PM
Global Blood Therapeutics prices upsized $300M of notes offering Seeking Alpha - 12/15/2021 1:20:54 AM
GBT Announces Pricing of Upsized Offering of $300.0 Million of Convertible Senior Notes GlobeNewswire Inc. - 12/15/2021 1:04:27 AM
GBT slumps after announcing offering of $250.0M in convertible senior notes Seeking Alpha - 12/14/2021 8:04:01 AM
GBT Announces Proposed Offering of $250.0 Million of Convertible Senior Notes GlobeNewswire Inc. - 12/14/2021 7:28:19 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/13/2021 1:11:42 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/13/2021 9:02:20 AM
GBT Presents Positive Results from Phase 1 Study of GBT021601 in Patients with Sickle Cell Disease and Healthy Volunteers at ASH Annual Meeting and Exposition GlobeNewswire Inc. - 12/13/2021 9:00:00 AM
GBT Presents Positive New Data on Oxbryta® (voxelotor) in Patients with Sickle Cell Disease at ASH Annual Meeting and Exposition GlobeNewswire Inc. - 12/12/2021 9:00:00 AM
GBT Announces New Employment Inducement Grants GlobeNewswire Inc. - 12/9/2021 8:00:00 AM
GBT Supports the ASH Research Collaborative's Data Hub Sickle Cell Disease Program PR Newswire (US) - 12/2/2021 8:00:00 AM
GBT Supports the ASH Research Collaborative’s Data Hub Sickle Cell Disease Program GlobeNewswire Inc. - 12/2/2021 8:00:00 AM
Goldmind   Thursday, 04/05/18 01:25:24 PM
Re: None
Post # of 38 
What turd! Company is going under

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences